1-5 of 5
chronic lymphocytic leukemia refractory
Close
Sort by
Journal Articles

Safety profiles of novel agent therapies in CLL

Inhye E. Ahn, Matthew S. Davids
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 354–357.
https://doi.org/10.1182/asheducation-2017.1.354
Published: 2017
Journal Articles

Patterns of resistance to B cell–receptor pathway antagonists in chronic lymphocytic leukemia and strategies for management

Jennifer A. Woyach
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 355–360.
https://doi.org/10.1182/asheducation-2015.1.355
Published: 2015
Journal Articles

Prognostic markers and standard management of chronic lymphocytic leukemia

Stephan Stilgenbauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 368–377.
https://doi.org/10.1182/asheducation-2015.1.368
Published: 2015
Journal Articles

The Treatment of Relapsed Refractory Chronic Lymphocytic Leukemia

Jennifer R. Brown
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 110–118.
https://doi.org/10.1182/asheducation-2011.1.110
Published: 2011
Journal Articles

Alemtuzumab Use In Relapsed and Refractory Chronic Lymphocytic Leukemia

Jon E. Arnason, Jennifer R. Brown
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 119–120.
https://doi.org/10.1182/asheducation-2011.1.119
Published: 2011